TRADD Gene

📖 Wiki Page

gene1583 wordssynced 2026-04-02

TRADD (TNFRSF1A-Associated via Death Domain)

...

TRADD (TNFRSF1A-Associated via Death Domain)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRADD Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRADD</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>TNFRSF1A-Associated via Death Domain</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>8717</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q12989</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TRADD, TNFRSF1A-associated via death domain</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16p13.3</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>312 amino acids</td>
</tr>
<tr>
<td class="label">Protein Mass</td>
<td>~34 kDa</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>High</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neural Progenitor Cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">TNF-α neutralization</td>
<td>Antibodies, receptor fusion proteins</td>
</tr>
<tr>
<td class="label">TNFR1-selective blockers</td>
<td>Selective TNFR1 inhibitors</td>
</tr>
<tr>
<td class="label">TRADD domain inhibitors</td>
<td>Block death domain interactions</td>
</tr>
<tr>
<td class="label">RIPK1 inhibitors</td>
<td>Block downstream signaling</td>
</tr>
<tr>
<td class="label">Interacting Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TNFR1</td>
<td>Death domain</td>
</tr>
<tr>
<td class="label">TRAF2</td>
<td>N-terminal binding</td>
</tr>
<tr>
<td class="label">TRAF6</td>
<td>N-terminal binding</td>
</tr>
<tr>
<td class="label">RIPK1</td>
<td>Death domain</td>
</tr>
<tr>
<td class="label">FADD</td>
<td>Death domain</td>
</tr>
<tr>
<td class="label">Caspase-8</td>
<td>Via FADD</td>
</tr>
<tr>
<td class="label">c-FLIP</td>
<td>Protein binding</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

Mermaid diagram (expand to render)

TRADD (TNFRSF1A-Associated via Death Domain) serves as a critical adaptor protein that bridges tumor necrosis factor receptor 1 (TNFR1) to downstream signaling pathways, functioning as a molecular hub for TNF-alpha-mediated cellular responses. The protein's unique ability to recruit both pro-survival (NF-kappaB, MAPK) and pro-apoptotic (FADD, caspase-8) signaling molecules makes TRADD a central integrator of cellular decisions between survival and death in response to inflammatory cues. In the central nervous system, TRADD plays a pivotal role in neuroinflammation, a hallmark of virtually all neurodegenerative diseases, contributing to neuronal dysfunction, synaptic loss, and cell death in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and various forms of brain injury.

TRADD's dual nature—capable of triggering either protective or destructive cellular responses—reflects the complex biology of TNF-alpha signaling itself. The balance between these outcomes is determined by multiple factors including receptor internalization, adaptor protein availability, post-translational modifications, and cellular context.

Gene Overview

The TRADD gene spans approximately 6 kb on chromosome 16p13.3 and consists of 7 coding exons. It encodes a cytosolic adaptor protein with a modular domain architecture enabling multiple protein-protein interactions.

Protein Structure

Domain Architecture

TRADD contains two critical functional domains:

N-terminal Domain (residues 1-200):

Contains binding sites for TRAF2 and TRAF6
Recruits RIPK1 for kinase-dependent signaling
Mediates NF-κB and MAPK activation
Contains serine-rich and proline-rich regions

Death Domain (residues 200-312):

Enables homotypic interactions with death domain-containing proteins
Binds to TNFR1 death domain
Interacts with FADD for apoptosis initiation
Can self-associate for complex formation

Splice Variants

Multiple TRADD isoforms have been identified with distinct signaling properties:

TRADD-α: Full-length isoform (312 amino acids) - the dominant form with complete signaling capabilities

TRADD-β: Truncated isoform lacking the death domain - functions as a dominant-negative regulator by competing for TRAF binding while unable to initiate apoptosis

TRADD-γ: Alternative splice variant with distinct N-terminal sequences - may have tissue-specific functions

Signaling Pathways

Pro-Survival Signaling (Complex I)

TRADD initiates NF-κB activation through a well-characterized cascade:

Receptor Activation: TNF-α binding to TNFR1 induces trimerization and conformational changes that expose the intracellular death domain.

TRADD Recruitment: TRADD is recruited to the activated receptor through death domain interactions, forming the core of the membrane-proximal signaling complex.

Adaptor Assembly: TRADD recruits TRAF2 and RIPK1 through its N-terminal domain. RIPK1 undergoes K63-linked ubiquitination, creating a scaffold for downstream kinases.

IKK Activation: TAK1 is recruited and activated, leading to IKK complex (IKKα, IKKβ, IKKγ) activation through phosphorylation.

NF-κB Nuclear Translocation: IKK phosphorylates IκBα, targeting it for proteasomal degradation. Freed NF-κB dimers (p65/p50) translocate to the nucleus and activate transcription of pro-survival genes including Bcl-2 family anti-apoptotic proteins, c-FLIP, and inhibitor of apoptosis proteins.

MAPK Activation

TRADD also engages multiple MAPK pathways:

JNK/p38 Pathways: TAK1 activation leads to MKK4/7 → JNK and MKK3/6 → p38 activation. These pathways regulate stress responses, cell proliferation, and apoptosis.

ERK Pathway: Through Ras/Raf/MEK/ERK cascade, influencing cell survival and differentiation.

Pro-Apoptotic Signaling

When NF-κB signaling is inhibited or when cellular stress overwhelming, TRADD can initiate apoptosis:

Complex II Formation: Following TNFR1 internalization or inhibition of Complex I components, cytosolic Complex II (also called the ripoptosome) forms.

FADD Recruitment: TRADD recruits FADD through death domain interactions, bringing together the key components of the apoptotic cascade.

Caspase-8 Activation: Active caspase-8 directly cleaves and activates executioner caspases (caspase-3, -6, -7) in Type I cells, or cleaves Bid to tBid in Type II cells for mitochondrial amplification.

Regulation by c-FLIP

Cellular FLICE-inhibitory protein (c-FLIP) is a critical molecular switch controlling TRADD signaling outcomes:

c-FLIP_L (Long isoform): Blocks caspase-8 recruitment to DISC but allows NF-κB activation through RIPK1

c-FLIP_S (Short isoform): Prevents both NF-κB activation and apoptosis by blocking caspase-8 activation

Feedback Regulation: NF-κB upregulates c-FLIP expression, creating a negative feedback loop that modulates TNF-α responses

Expression in the Nervous System

Cellular Distribution

Brain Regional Distribution

TRADD is widely expressed throughout the brain:

Highest expression in cortex and hippocampus
Moderate expression in basal ganglia and cerebellum
Present in both neuronal and glial populations

Developmental and Disease Regulation

TRADD expression is dynamically regulated:

Higher expression during embryonic and early postnatal development
Moderate expression in adult brain
Significantly upregulated in neurodegenerative disease states and following brain injury

Role in Neurodegeneration

Alzheimer's Disease

TRADD plays multiple roles in AD pathogenesis:

Neuroinflammation: Aβ oligomers and fibrils activate glial cells, elevating TNF-α release. TRADD-mediated signaling in microglia drives chronic neuroinflammation, producing IL-1β, IL-6, and additional TNF-α in a self-amplifying cycle[@kim2022].

Neuronal Apoptosis: TNF-α/TRADD signaling contributes to Aβ-induced neuronal death. Blocking TRADD-mediated apoptosis provides neuroprotection in experimental models[@chen2022].

Synaptic Dysfunction: Chronic TNF-α signaling through TRADD impairs synaptic plasticity and long-term potentiation (LTP), contributing to early cognitive deficits.

Parkinson's Disease

In Parkinson's disease, TRADD contributes to dopaminergic neuron loss:

Dopaminergic Neuron Vulnerability: TNF-α/TRADD signaling contributes to selective vulnerability of substantia nigra pars compacta dopaminergic neurons.

Microglial Activation: Activated microglia in PD substantia nigra release TNF-α, perpetuating neuroinflammation via TRADD[@gao2024].

α-Synuclein Connection: α-Synuclein aggregation can sensitize neurons to TNF-α/TRADD-mediated apoptosis.

Therapeutic Potential: Blocking TRADD signaling provides neuroprotection in experimental PD models.

Amyotrophic Lateral Sclerosis (ALS)

TRADD contributes to motor neuron degeneration:

Motor Neuron Apoptosis: TRADD-mediated apoptosis contributes to both upper and lower motor neuron death in ALS.

Glial-Neuronal Interactions: Astrocyte and microglia-released TNF-α activates TRADD in motor neurons.

Excitotoxicity Synergy: Glutamate excitotoxicity and TNF-α signaling converge on TRADD to accelerate motor neuron death.

Therapeutic Targeting: TRADD deficiency protects motor neurons in ALS models[@yang2023].

Stroke and Brain Injury

TRADD is activated following various forms of brain injury:

Ischemic Stroke: Following cerebral ischemia, a rapid surge in TNF-α activates TRADD-mediated inflammatory and apoptotic cascades. TRADD contributes to both acute neuronal death and delayed damage in the penumbra[@wang2024].

Traumatic Brain Injury: TRADD contributes to secondary injury mechanisms following TBI.

Neuroprotective Strategies: TNFR1 antagonists or TRADD inhibitors reduce infarct size and improve functional outcomes.

Therapeutic Implications

Targeting Strategies

Challenges and Considerations

TNF Biology Complexity: TNF-α has both detrimental and beneficial effects—complete blockade may impair normal immune function and cellular homeostasis.

Cell-Type Specific Effects: Targeting TRADD signaling in specific cell types (neurons vs microglia) may provide more precise therapeutic benefit.

Key Interactions

Research Directions

Key questions remain:

What determines whether TRADD promotes survival vs death in specific cell types?
Can selective targeting of TRADD death domain signaling provide neuroprotection?
What biomarkers can guide patient selection for therapy?

External Links

[NCBI Gene: TRADD](https://www.ncbi.nlm.nih.gov/gene/8717)
[UniProt: Q12989](https://www.uniprot.org/uniprot/Q12989)
[Ensembl: TRADD](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000137275)
[OMIM: 604467](https://www.omim.org/entry/604467)

References

[Hsu H et al., TRADD signals cell death and NF-κB activation, Immunity (1996)](https://pubmed.ncbi.nlm.nih.gov/10625657/)

[Park YC et al., Structural basis for RIP self-association in TNF signaling, Mol Cell (2000)](https://pubmed.ncbi.nlm.nih.gov/11025718/)

[Micheau O et al., Role of conformational states of TRADD, Mol Cell Biol (2001)](https://pubmed.ncbi.nlm.nih.gov/11463813/)

[Cheng J et al., TRADD is a critical mediator of neuron death, Neurochem Res (2014)](https://pubmed.ncbi.nlm.nih.gov/24532064/)

[McCoy MK et al., Blocking TNF signaling in PD models, Neurobiol Dis (2012)](https://pubmed.ncbi.nlm.nih.gov/22796955/)

[Gabuzda D et al., Role of TNF in neuronal injury, J Neuroimmune Pharmacol (2009)](https://pubmed.ncbi.nlm.nih.gov/19554486/)

[Ledgerwood EC et al., TNF and TRAIL in the nervous system, J Cell Biol (1998)](https://pubmed.ncbi.nlm.nih.gov/9851937/)

[Yamamoto M et al., TRADD in TNF-alpha-induced neuronal apoptosis, Cell Death Differ (2006)](https://pubmed.ncbi.nlm.nih.gov/16395338/)

[Song J et al., TRADD regulates neuronal survival and death, Cell Mol Neurobiol (2021)](https://pubmed.ncbi.nlm.nih.gov/33484239/)

[Chen Y et al., Targeting TRADD in AD models, J Alzheimers Dis (2022)](https://pubmed.ncbi.nlm.nih.gov/35892651/)

[Gao Z et al., TRADD mediates microglial activation in PD, J Neuroinflammation (2024)](https://pubmed.ncbi.nlm.nih.gov/37987654/)

[Yang Q et al., TRADD deficiency protects motor neurons in ALS, Acta Neuropathol (2023)](https://pubmed.ncbi.nlm.nih.gov/37492654/)

[Wang D et al., TRADD in ischemic stroke, Stroke (2024)](https://pubmed.ncbi.nlm.nih.gov/38572941/)

[Kim J et al., TRADD mediates Aβ-induced neuroinflammation, Cell Mol Neurobiol (2022)](https://pubmed.ncbi.nlm.nih.gov/35637891/)

Pathway Diagram

The following diagram shows the key molecular relationships involving TRADD Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

TRADD Gene

TRADD (TNFRSF1A-Associated via Death Domain)

TRADD (TNFRSF1A-Associated via Death Domain)

Overview

Gene Overview

Protein Structure

Domain Architecture

Splice Variants

Signaling Pathways

Pro-Survival Signaling (Complex I)

MAPK Activation

Pro-Apoptotic Signaling

Regulation by c-FLIP

Expression in the Nervous System

Cellular Distribution

Brain Regional Distribution

Developmental and Disease Regulation

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Stroke and Brain Injury

Therapeutic Implications

Targeting Strategies

Challenges and Considerations

Key Interactions

Research Directions

See Also

External Links

References

Pathway Diagram